Cattrini C, Messina C, Mennitto A, Di Maio M, et al. Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)". Int J Cancer 2022;151:2291-2292.
PMID: 35975447